C07D 307/74
By hydrazino or hydrazono or such substituted radicals
Official title: by hydrazino or hydrazono or such substituted radicals
C07D307/74 (By hydrazino or hydrazono or such substituted radicals) appears on 10 US grants and 4 published applications in this corpus.
Search patents in C07D- Granted patents
- 10
- Published applications
- 4
- Assignees
- 8
- Inventors
- 33
- Latest grant
- 12 Apr 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 2 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 1 | 0 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Arylalkene derivatives and use thereof as selective estrogen receptor modulators12 Apr 2016US 9,309,211 B2Centaurus Biopharma Co., Ltd.
- Hydrazone and diacyl hydrazine compounds and methods of use27 Aug 2013US 8,518,968 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Factors participating in degranulation of mast cells, DNAs encoding the same, method of screening of these factors and the inhibitors19 Sep 2006US 7,108,987 B2Dainippon Pharmaceutical Co., Ltd.
- 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof21 Sep 2004US 6,794,400 B2Cytovia, Inc.
- Preparation of polycyclic ethers13 Oct 1992US 5,155,238 AFirmenich SA
- Novel arylalkene derivatives and use thereof as selective estrogen receptor modulators15 Jan 2015US 2015/0018341 A1Centaurus Biopharma Co., Ltd.
- Hydrazone and diacyl hydrazine compounds and methods of use13 Dec 2012US 2012/0316198 A1The United States of American, as Represented by the Secretary, Dept. of Health and Human Services
- Factors participating in degranulation of mast cells, dnas encoding the same, method of screening of these factors and the inhibitors31 Jul 2003US 2003/0143633 A1Dainippon Pharmaceutical Co., Ltd.
- 4-substituted-1- (arylmethylidene) thiosemicarbazide, 4-substituted-1- (arylcarbonyl) thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof6 Mar 2003US 2003/0045581 A1Cytovia, Inc.
Most cited
By later US patents
- 3-Hydroxybenzyl-oxadiazolone and -thiadiazolone derivatives15US 3,971,803 ACiba-Geigy Corporation · 1976
- Arylalkene derivatives and use thereof as selective estrogen receptor modulators12US 9,309,211 B2Centaurus Biopharma Co., Ltd. · 2016
- (Nitrofuryl)pyrazoles, their synthesis and use, and compositions containing them10US 4,093,812 AByk Gulden Lomberg Chemische Fabrik GmbH · 1978
- Process for the preparation of polycyclic ethers7US 5,077,417 AFirmenich SA · 1991
- 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof4US 6,794,400 B2Cytovia, Inc. · 2004